Bangalore: At the inauguration of Eurofins Scientifics' new Bangalore facility, Dr Matthias-Wilbur Weber, group executive vice president, Eurofins Scientific said, "India is a critical market, which is strategically important for our future growth. India will help us grow at the global level from the current 1.3 billion Euros to 2 billion Euros by 2017.

"This new facility demonstrates our commitment to the Indian market, which is strategically important for our growth in the long term. Eurofins is one of the few international players in the testing business to invest in a wholly-owned facility in India. We will expand our offering to bring more and more of the Eurofins portfolio of services to customers here."

Eurofins has been in India since 2009. The new facility is a mix of laboratories and office space measuring over 48,357 sq ft.

Mr Sanjeev Khatri, MD, Eurofins India expressed, "The pace of growth and diversity of activities meant that all entities could not be accommodated in single rented premises. With most of our businesses starting up and quickly reaching profitability, it became quite clear that India will continue to be an attractive market for Eurofins and we shall continue to grow our presence here."

Founded in 1987, the company operates five businesses overall in India, out of which four of them including genomics, food & feed testing, pharma services, and IT Solutions, are located in the new facility at Hoodi, Whitefield, in Bangalore.

However, its AgroScience Services business operates from Coimbatore in Tamil Nadu.

The company has leased 6 acres of land in Coimbatore where field trials of plant protection and other agrochemicals are carried out.

By September 2014, Eurofins plans to have 300 employees in India.

The company's clientele includes global companies in food, retail and pharma, along with reputed private and public research institutions.